Updated as of July 10, 2019
Investors are cannabis crazy right now and for good reason. This booming industry has incredible growth potential and no one wants to miss out.
Like our friend Michael Vodicka at Cannabis Stock Trades says, cannabis is one of the greatest opportunities of our lifetime IF you know how to separate legitimate investments from the sea of duds.
Our scanning and rating tools continuously rank the best cannabis stocks for members.
Below are strongest-trending cannabis stocks as rated by MarketClub Smart Scan and Trade Triangle technology.
Strongest Upward Trending Cannabis Stocks
Innovative Industrial Properties, Inc. (IIPR)
Innovative Industrial Properties, Inc. is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities.
Symbol: IIPR
Avg. Volume: 416,832
Market Cap: 1.33B
Last Monthly Green Trade Triangle: 8/1/17 @ $18.42
Smart Scan Score: +100
Cara Therapeutics, Inc. (CARA)
This clinical-stage biopharmaceutical company focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States.
Symbol: CARA
Avg. Volume: 770,520
Market Cap: 895.2M
Last Monthly Green Trade Triangle: 3/13/19 @ $18.80
Smart Scan Score: +100
GrowGeneration Corp. (GRWG)
GrowGeneration Corp., through its subsidiaries, owns and operates retail hydroponic and organic gardening stores in the United States. It offers horticultural, organics, and lighting and hydroponics products, including lighting fixtures, nutrients, seeds and growing media, systems, trays, fans, filters, humidifiers and dehumidifiers, timers, instruments, water pumps, irrigation supplies, and hand tools.
Symbol: GRWG
Avg. Volume: 99,280
Market Cap: 99.22M
Last Monthly Green Trade Triangle: 5/16/19 @ $3.62
Smart Scan Score: +100
Zynerba Pharmaceuticals, Inc. (ZYNE)
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders.
Symbol: ZYNE
Avg. Volume: 2,387,896
Market Cap: 317.1M
Last Monthly Green Trade Triangle: 4/2/19 @ $6.49
Smart Scan Score: +90
GW Pharmaceuticals (GWPH)
GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. Its lead product is Epidiolex, an oral medicine for the treatment of refractory childhood epilepsies, as well as for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, and infantile spasms.
Symbol: GWPH
Avg. Volume: 380,453
Market Cap: 5.37B
Last Monthly Green Trade Triangle: 2/15/19 @ $152.28
Smart Scan Score: +90
It doesn’t matter if a cannabis stock is shooting up like a rocket or crashing like an asteroid – our scanning and signaling technology will do the hard work and tell you when to buy, short, or sit out altogether.
Join MarketClub now to get the signals for the best cannabis stocks as well as over 300K additional markets!
